Officers
President
Terry A. Jacobson, MD, FNLA
Atlanta, GA
Financial Disclosures
President Elect
Paul E. Ziajka, MD, PhD, FNLA
Winter Park, FL
Financial Disclosures
Treasurer
Ralph La Forge, MSc, FNLA
Durham, NC
Financial Disclosures
Secretary
Charles R. Harper, MD, FNLA
Duluth, GA
Financial Disclosures
Immediate Past-President
Wm. James Howard, MD, MACP, FNLA
Edgewater, MD
Financial Disclosures
Board Members
Term Expiring 2014
Mary H. Honkanen, MD, FNLA
Mobile, AL
Financial Disclosures
Jan L. McAlister, NP, MSN, BSN, FNLA
Smyrna, GA
Financial Disclosures
Cynthia Gayle Rodriguez, ARNP, MS, FNP-BC, CLS
Tampa, FL
Financial Disclosures
Thomas Rhyne White, MD
Cherryville, NC
Financial Disclosures
Term Expiring 2013
Lori A. Alexander, MSHS, RD, CCRC, FNLA
Ponte Vedra, FL
Financial Disclosures
Harold E. Bays, MD, FNLA
Louisville, KY
Financial Disclosures
Pamela B. Morris, MD
Mt. Pleasant, SC
Financial Disclosures
Gregory S. Pokrywka, MD, FACP, FNLA
Baltimore, MD
Financial Disclosures
Term Expiring 2012
Thomas Avery Barringer, MD, FNLA
Charlotte, NC
Financial Disclosures
William C. Cromwell, MD, FNLA
Raleigh, NC
Financial Disclosures
Sandra J. Kreul, ARNP, FNLA
Tampa, FL
Financial Disclosures
Barbara S. Wiggins, PharmD, FNLA
Summerville, SC
Financial Disclosures
Executive Director
Christopher Seymour, MBA
(Disclosure not applicable)
|

Terry A. Jacobson, MD, FNLA
Fall 2012 Clinical Lipid Update
September 14-16, 2012
Hosted by NELA and SELA
Charlotte Westin
Charlotte, NC
Southeast Lipid Association names Terry Jacobson, MD, FNLA, as President:
Dr. Jacobson is currently the Director of the Office of Health Promotion and Disease Prevention at Emory
University in Atlanta, GA. His specific expertise is in hyperlipidemia, nutrition and drug management of
hypercholesterolemia, coronary heart disease (CHD) risk reduction strategies, and translating cardiovascular
prevention into practice. He also serves as Co-Director of the Lipid and Cardiovascular Risk Reduction
Program at Grady Health Systems in Atlanta, GA.
A graduate of Cornell University and Cornell University Medical College, Dr. Jacobson interned at New York
University Medical Center/Bellevue Hospital in New York City. After completing a Robert Wood Johnson Clinical
Scholar's Fellowship at the University of Pennsylvania, he became Director of Penn's Lipid Evaluation and CHD
Risk Assessment Center. He is currently Professor of Medicine at Emory University and is an active clinician,
educator, and researcher.
Dr. Jacobson has published and lectured extensively in the field of hypercholesterolemia, CHD risk modification,
cost-effectiveness, lipid drug safety, and the dietary and pharmacologic treatment of hyperlipidemia.
Since 1990, he has published over 100 peer reviewed articles in the Journal of the American Medical Association,
the American Journal of Cardiology, Archives of Internal Medicine, Annals of Internal Medicine, the American
Journal of Medicine, Current Opinion in Lipidology, and others. He has been invited to present at many national
and international meetings on topics ranging from drug therapy for dyslipidemia to new directions in CHD
prevention.
Dr. Jacobson has been elected to Fellowship of the American College of Physicians, the American College of
Preventive Medicine, and the Council of Epidemiology and Prevention of the American Heart Association. He has
served on the National Advisory Board of the United States Agency for Healthcare Research and Quality (AHRQ).
He currently serves as a Board Member of the National Lipid Association and is President-Elect of the Southeast
Lipid Association (SELA). He was the Chairman of the National Lipid Association's (NLA) Taskforce on Non-HDL
Cholesterol and was involved in the Taskforce on Statin Safety and on the Taskforce for the Safety of Non-Statin
Drugs. He is also a founding Board member of the Cardiovascular and Metabolic Health Foundation.
Serving the States of: Maryland, Washington, Virginia, West Virginia, North Carolina, South Carolina, Florida, Georgia, Alabama, Mississippi, Tennessee, Kentucky, Arkansas
|